{
    "Trade/Device Name(s)": [
        "Psychemedics Microplate EIA for Amphetamine in Hair"
    ],
    "Submitter Information": "Psychemedics Corporation",
    "510(k) Number": "K130811",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033743"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ"
    ],
    "Summary Letter Date": "March 22, 2013",
    "Summary Letter Received Date": "March 25, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine"
    ],
    "Specimen Type(s)": [
        "Head hair",
        "Body hair"
    ],
    "Specimen Container(s)": [
        "V-shaped aluminum foil sample holder",
        "Sample acquisition card envelope"
    ],
    "Instrument(s)/Platform(s)": [
        "Microplate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Microplate assay"
    ],
    "Methodologies": [
        "Enzyme immunoassay",
        "Digestion and extraction",
        "LC/MS/MS confirmation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Psychemedics Microplate EIA for preliminary qualitative detection of amphetamine in human head and body hair specimens",
    "Indications for Use Summary": "Preliminary qualitative detection of amphetamine in human head and body hair at a 3 ng/10 mg hair cutoff to identify amphetamine use; intended exclusively for Psychemedics use with confirmatory testing by GC/MS or LC/MS/MS",
    "fda_folder": "Toxicology"
}